H.R. 3 - Stem Cell Research Enhancement Act
To amend the Public Health Service Act to provide for human embryonic stem cell research. This bill is identical to S. 5 (Status: Introduced).
Introduced: January 5, 2007
Sponsor: Rep. Diana DeGette (D-CO)
Last Action: Jan 12, 2007: Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 6
Passed: Jan. 11, 2007 by a vote of 253-174
View Full Text: View Full Text of Bill
H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007
To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries
Introduced: January 5, 2007
Sponsor: Rep. John Dingell (D-MI)
Last Action: Jan 12, 2007: On passage Passed by recorded vote: 255 - 170 (Roll no. 23)
View Full Text: View Full Text of Bill
H.R. 6 - RU-486 Suspension and Review Act of 2007
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug commonly known as RU-486 is deemed to have been withdrawn, to provide for the review by the Comptroller General of the United States of the process by which the Food and Drug Administration approved such drug, and for other purposes.
Introduced: January 4, 2007
Sponsor: Rep. Roscoe Bartlett (R-MD)
Last Action: Jan 4, 2007: Referred to the House Committee on Energy and Commerce
View Full Text: View Full Text of Bill
HR. 331 - Drug Expiration Date Study
To direct the Secretary of Veterans Affairs to conduct a study of the accuracy of expiration dates on certain prescription drugs maintained by the Department of Veterans Affairs.
Introduced: January 9, 2007
Sponsor: Rep. Virginia Brown-Waite (R-FL)
Last Action: Jan 9, 2007: Referred to the House Committee on Veterans' Affairs
View Full Text: View Full Text of Bill
H.R. 380 - Pharmaceutical Market Access and Drug Safety Act of 2007
To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. This bill is identical to S. 242
Introduced: January 10, 2007
Sponsor: Rep. Rahm Emanuel (D-IL)
Last Action: Jan 10, 2007: Referred to the House Committee on Energy and Commerce.
View Full Text: View Full Text of Bill
H.R. 780 - Counterfeit Drug Prevention Act of 2007
Expands on the penalties for counterfeiting drugs. This bill is in the first stage of the legislative process where the bill is considered in committee and may undergo significant changes in markup sessions. The bill has been referred to the following committees: House Energy and Commerce and House Judiciary.
Introduced: January 31, 2007
Sponsor: Rep. Henry Waxman (D-CA); Sens. Charles Schumer (D-NY), Hillary Rodham Clinton (D-NY)
Last Action: Feb 14, 2007: Referred to House Judiciary
View Full Text: View Full Text of Bill
H.R. 1038 - Access to Life-Saving Medicine Act
To amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products, and for other purposes. (Bill would allow FDA to approve generic versions of biotechnology medications through an "abbreviated process.")
Introduced: February 14, 2007
Sponsor: Rep. Henry Waxman (D-CA)
Last Action: Jan 31, 2007: Referred to House Judiciary
View Full Text: View Full Text of Bill
S. 28 - Generics First Act of 2007
A bill to amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary.
Introduced: January 4, 2007
Sponsor: Sen. Herbert Kohl (D-WI)
Last Action: Jan 4, 2007: Read twice and referred to the Committee on Finance
View Full Text: View Full Text of Bill
S. 137 - Preserving Medicare for All Act 0f 2007
A bill to amend title XVIII of the Social Security Act to provide additional beneficiary protections.
Introduced: January 4, 2007
Sponsor: Sen. Benjamin Cardin (D-MD)
Last Action: Jan 4, 2007: Read twice and referred to the Committee on Finance
View Full Text: View Full Text of Bill
S. 414 - Cloned Food Labeling Act
A bill to amend the Federal Food, Drug, and Cosmetic Act and the Federal Meat Inspection Act to require that food that contains product from a cloned animal be labeled accordingly, and for other purposes.
Introduced: January 26, 2007
Sponsor: Sen. Barbara Mikulski (D-MD)
Last Action: Jan 26, 2007: Read twice and referred to the Committee on Health, Education, Labor, and Pensions
View Full Text: View Full Text of Bill
S. 438 - Fair Prescription Drug Competition Act
A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Last Action: Jan 30, 2007: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
View Full Text: View Full Text of Bill
S. 484 - Drug Safety and Oversight (Kennedy-Enzi)
A bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes.
Introduced: February 1, 2007
Sponsor: Sen. Michael Enzi (R-WY)
Last Action: Feb 1, 2007: Read twice and referred to the Committee on Health, Education, Labor, and Pensions
View Full Text: View Full Text of Bill
S. 623 - Access to Life-Saving Medicine Act
A bill to amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products, and for other purposes.
Introduced: 2/15/2007
Sponsor: Sen. Charles Schumer (D-NY)
Last Action: Referred to Senate Committee on Health, Education, Labor, and Pensions.
View Full text: View Full Text of Bill
